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Vaccine distribution programs have historically targeted individuals at high risk of complications due to
influenza. Despite recommendations from the Advisory Committee on Immunization Practices, vaccination
coverage among high-risk populations has been generally low. This review systematically summarizes the recent
literature evaluating programs in different settings, from within medical settings to venue-based and community-
based approaches, in an effort to identify successful program components. The published literature was identified
by using the MEDLINE database from 1990 to 2006 covering studies that reported on interventions or programs
aimed at vaccinating high-risk populations. The authors reviewed 56 studies. In the United States, the Healthy
People 2010 goals included 90% vaccination coverage for adults aged 65 years and 60% for high-risk adults
aged 18–64 years. Only a handful of the studies reviewed managed to meet those goals. Interventions that
increased vaccination coverage to Healthy People 2010 goals included advertising, provider and patient mailings,
registry-based telephone calls, patient and staff education, standing orders coupled with standardized forms,
targeting of syringe exchange customers, and visiting nurses. Few studies evaluated the impact of vaccination
programs by race/ethnicity and socioeconomic status. Few studies targeted individuals outside of the health-care
and social services sectors. Given the growing disparities in health and health-care access, understanding the
way in which interventions can remedy disparities is crucial.
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INTRODUCTION
Influenza is associated with significant morbidity and
mortality in the United States. Between the 1990–1991 and
1998–1999 influenza seasons, the rate of influenza-related
primary respiratory and circulatory hospitalizations ranged
from 62.6 to 159.1 per 100,000 person-years; the rate for
primary pneumonia and influenza hospitalizations specifi-
cally ranged from 31.0 to 71.4 per 100,000 person-years (1).
During the same interval, the influenza-related morality
rates were 19.6 per 100,000 person-years for all causes, 13.8
for underlying respiratory and circulatory deaths, and 3.1 for
underlying pneumonia and influenza deaths (2). The highest
rates of influenza-related mortality are seen among individ-
uals aged 65 years or older: 132.5 per 100,000 person-years
for all-cause deaths, 98.3 for underlying respiratory and
circulatory deaths, and 22.1 for underlying pneumonia and
influenza deaths (2).
Vaccine distribution programs have historically targeted
individuals at high risk of complications due to influenza
(3). Mathematical modeling suggests that focusing influ-
enza control efforts on high-risk groups (high risk in terms
of both susceptibility and contagiousness) can offer a con-
siderable advantage in terms of reduction of infectious dis-
ease compared with interventions that target more general
populations (4). Most current recommendations suggest
prioritizing vaccination for individuals at high risk of com-
plications due to influenza virus infection. The Advisory
Committee on Immunization Practices classified high-risk
groups to include, but not be limited to, adults aged 65 years
or older, children aged 6–23 months, pregnant women, and
individuals with chronic medical conditions, especially pul-
monary or cardiovascular disorders (5).
Given the higher risk of morbidity and mortality among
high-risk groups, the Healthy People 2010 initiative has set
an influenza vaccination goal of 90 percent coverage for
noninstitutionalized adults aged 65 years or older and 60
percent for noninstitutionalized high-risk adults aged 18–64
years (6). However, data from the 2003 Behavioral Risk
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Factor Surveillance System study suggest that vaccination
coverage is lower: coverage among adults aged 65 years or
older was 69.9 percent and among adults aged 18–64 years
was 34.0 percent for those with asthma and 49.0 percent
for those with diabetes (7). During the 2004–2005 influenza
season, when there was a significant vaccine shortage, vacci-
nation coverage was estimated to be 62.7 percent among
adults aged 65 years or older and 25.5 percent among adults
aged 18–64 years with a high-risk condition (8). Further-
more, influenza vaccination coverage is not evenly distrib-
uted. Data from theNationalHealth InterviewStudy revealed
significant differences in influenza vaccination coverage
among elderly adults by race/ethnicity, with rates being
higher among Whites, followed by Hispanics and Blacks
(66 percent vs. 50 percent and 46 percent, respectively) (9).
Rates of vaccination have been low despite recommenda-
tions. Avariety of settings and approaches have been utilized
in the effort to increase vaccination rates among individuals
at high risk of complications due to influenza infection. This
review systematically summarizes the recent literature eval-
uating programs in different settings, from within medical
settings to venue-based and community-based approaches,
in an effort to identify the features of such programs that are
most successful and that may guide efforts to increase
vaccination rates nationwide. We also considered limitations
in the current body of literature, focusing on areas for further
research and program development.
REVIEW OF THE LITERATURE
The potential scope of the literature that may be con-
sidered relevant to the distribution of influenza vaccination
is vast. In light of recent reviews examining immunization
delivery methods that have included much of the older lit-
erature (10–12), we chose to limit the focus of our review to
studies conducted after 1990. Given the large numbers of
studies that allude to vaccine delivery methods, we limited
our review to studies that were explicitly, at least in part, con-
cerned with evaluating an intervention or program to either
distribute or increase uptake of influenza vaccine among in-
dividuals at high risk.
The published literature was identified by using the
MEDLINE database (National Library of Medicine, Be-
thesda, Maryland) from 1990 through early 2006, covering
both US and international studies that reported on interven-
tions or programs aimed at vaccinating high-risk popula-
tions. We considered randomized controlled trials, pre- and
postintervention evaluation studies, and simple evaluations
with and without controls. The search was limited to English-
language studies in biomedical research. Keywords and
terms used for the search included primarily the following:
influenza, vaccination, intervention, program, distribution, el-
derly, children, pregnant, diabetes, cardiovascular, cardiovas-
cular disease, chronic obstructive pulmonary disease, asthma,
chronic lung disease, and HIV.
FINDINGS
In this review, we move from the medical setting out into
community settings and discuss influenza vaccine distribu-
tion in five different contexts: 1) hospital/tertiary-care set-
tings, 2) primary-care settings, 3) venue-based (e.g., nursing
homes) targeted delivery, 4) large-scale regional programs,
and 5) community-based distribution programs. Table 1 pro-
vides details for each study, including year of publication,
location, setting, sample size and study type (i.e., random-
ized controlled trial, pre-post evaluation, and simple eval-
uations with and without controls), intervention content, and
study findings.
Hospital/tertiary-care settings
Hospital- and tertiary-care-based programs for increas-
ing influenza vaccination coverage generally focused on the
provider and included standing orders for influenza vacci-
nation and reminders to hospital staff. Two studies evaluated
the impact of standing orders on vaccination coverage. One
study of 761 elderly patients in a tertiary-care hospital that
implemented a standing order for influenza vaccination re-
ported that vaccination coverage increased from 45 percent
prior to admission to 67 percent after the inpatient inter-
vention; almost 40 percent of unvaccinated patients were
vaccinated (13). In a 10-year evaluation of a vaccination
program in a veterans’ hospital that implemented standing
orders and standardized forms, vaccination coverage in-
creased from 79 percent to 86 percent (14).
Reminder systems have also been evaluated. Dexter et al.
(15) assessed a computerized reminder system by using
a randomized controlled trial among 6,371 patients repre-
senting all patients discharged from six general medicine
wards in an urban hospital during an 18-month period. Four
general medicine teams were randomized to the intervention
team and four were randomized to the control team. Vacci-
nation coverage was 51.4 percent among eligible patients in
the intervention group compared with 1.0 percent in the
control group. Bloom et al. (16) evaluated fax reminders to
primary care physicians encouraging vaccination before
discharge among 103 physicians serving 153 patients aged
65 years or older; the vaccination rate before discharge was
less than 2 percent. Common reasons physicians gave for
not vaccinating before discharge included the following:
patient vaccinated prior to hospitalization (85 percent),
patient discharged prior to completion of treatment (47 per-
cent), and acute-care setting not appropriate to give vac-
cinations (40 percent). Claims data did not corroborate the
reports of past vaccination; for only 24 percent of patients
whom physicians identified as previously being vaccinated
for pneumococcus or influenza was there a claim in the
system of notation in their hospital medical record. How-
ever, the authors noted that claims data may have been
lagged or physicians may have billed for vaccinations sep-
arately and thus no claims were submitted. Despite the
limitations of the claims data, the authors concluded it was
unlikely that the rate of influenza vaccination prior to
admissions was as high as the physician reports suggested.
The structured setting of hospitals and tertiary-care
facilities provides an important opportunity for vaccination.
Standing orders and reminders appear to improve vaccina-
tion rates, but there are two problems. First, while the rates
were higher in the intervention groups, they still did not
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TABLE 1. Key studies that evaluated programs and interventions aimed at increasing influenza vaccination coverage, 1990–2005
Study, year
(reference no.)
Location Target group Setting Sample Study type Intervention Findings Result
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Hannah et al.,
2005 (61)
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meet theHealthy People 2010 goals, with one exception (14).
Second, and perhaps more importantly, these approaches
were limited to people hospitalized during the influenza
season. In 2003, 13.2 million people aged 65 years or older
were discharged from short-stay hospitals (17), representing
approximately 38 percent of the US population aged 65 years
or older. These facilities have limited ability to reach high-
risk individuals.
Primary-care settings
Primary care was the most common setting for studies of
mostly multicomponent vaccination programs for high-risk
populations, and interventions were directed at the patient,
provider, and organization levels. Of 30 studies evaluating
interventions in primary-care settings, patient-level com-
ponents were included in more than 75 percent of inter-
ventions. Patient mailings were among the most frequent
patient-level program components either alone (18–21) or in
combination with other intervention components (14, 22–
31). A variety of other patient-level interventions have been
evaluated, including telephone reminders (23, 26, 32–35),
patient education (36–39), home visits (27, 29, 40, 41),
clinic-based advertising (23, 38, 42), vaccination offers
during office visits (28), and case management (43). Twelve
studies included components aimed at improving provider
performance. Provider-level components included provider
reminders (22–24, 44), feedback to physicians and staff (22,
44, 45), provider education (23, 28, 36, 37, 43–47), provider
mailings (42), and provider e-mails (23). Nine studies used
organizational components including nurse-administered
vaccines with physicians’ order (24), standing orders (14,
25, 37, 46), standardized documentation (14, 45), vaccina-
tion clinics (14, 36, 39), and patient registries (43).
Because most programs included multiple components,
disentangling the independent effect of specific components
is challenging. In studies with a comparison group (e.g.,
pre-post evaluation or controlled trial), interventions that
included only patient mailings increased vaccination cov-
erage by 10–17 percent (18, 20, 21). For example, one
randomized controlled trial examined the impact of mail-
ings to parents of children with high-risk conditions that
strongly encouraged influenza vaccination for their child
(21). For those children who were not vaccinated after the
initial letter, a reminder letter was mailed 4 weeks later and
a postcard 4 weeks after that. Overall, vaccine coverage was
42 percent among the intervention group and 25 percent
among controls (p < 0.001). In studies with a comparison
group, vaccination coverage improved by 10–18 percent
with standing orders (25), by 7 percent with provider edu-
cation (47), and by 38 percent with a visiting nurse (41).
Three studies evaluated interventions with telephone re-
minders alone (33–35) or in combination with patient
mailings (26, 32), which resulted in 4–6 percent and 10–27
percent increases in vaccination coverage over the compar-
ison groups, respectively. One study examined the impact of
home health assessments, where vaccination was offered,
and found that those persons who accepted the home health
assessment were significantly more likely to have been
vaccinated than those who refused the home health assess-
ment (63.7 percent vs. 34.9 percent, p 5 0.001) (40).
Most studies contained two or more intervention compo-
nents. For example, Ahmed et al. (31) used up to two mailed
reminders to managed-care organization patients and pro-
vided an influenza tool kit to employers, which included edu-
cational messages to employers, advertising material targeted
to staff (e.g., flyers, newsletter articles, payroll stuffers), and
tips and a checklist for employer-sponsored vaccination clinics
at work sites. The authors observed only a 4 percent increase in
vaccination coverage for two postcards compared with one
among adults aged 50–64 years.
Although significant improvements were observed in
24 studies, one exception is noteworthy. Patel et al. (43)
evaluated a multidisciplinary asthma disease management
program that included a patient registry, asthma therapy
assessment, case management, and physician education. A
written home treatment plan was provided, which included
reminders for influenza vaccination. Although not a primary
target of the intervention, influenza vaccination was recom-
mended for individuals with chronic lung disease. The study
demonstrated reductions in hospitalizations and emergency
department visits (the primary goals); however, vaccination
coverage significantly decreased from 24.2 percent at base-
line to 15.0 percent at follow-up (p < 0.001). No explanation
was provided for the decrease.
Venue-based targeted delivery
An efficient method for vaccinating individuals at high
risk of influenza is to target venues frequented by high-risk
groups. While there is some overlap with respect to nursing
homes, we distinguish these venues from the previously
discussed primary- or tertiary-care settings based on loca-
tion. Primary- and tertiary-care settings were either hospital
based or situated in clinics or physician practices. Venues
frequented by high-risk groups included nursing homes,
which are specialized tertiary-care facilities, as well as
senior centers and community-based organizations such as
syringe exchange programs. Five such studies were pub-
lished (30, 48–51) between 1990 and 2006, four of which
focused specifically on long-term-care facilities and senior
centers (30, 48–50). In a study among the elderly, influenza
vaccination was offered to all residents in a nursing home,
resulting in an increase in vaccination coverage from 14
percent to 52 percent (50). Kreiger et al. (30) reported on
an intervention that utilized a senior center in Seattle,
Washington. When patient mailings, telephone calls to the
unvaccinated by peers, and computerized vaccination track-
ing were used, 50 percent of the intervention group that had
not been vaccinated the previous year was vaccinated com-
pared with 23 percent of the control group. Patient advertis-
ing, including a videotape about the benefits of the influenza
vaccination featuring a Colorado First Lady, and patient
education increased vaccination coverage from 85 percent
to 89 percent in long-term-care facilities (48).
Although not explicitly designated as a group at high risk
for influenza complications according to the Advisory Com-
mittee on Immunization Practices recommendations, in-
jection drugs users are generally at high risk for a variety of
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chronic conditions. One study evaluated influenza vaccine
distribution at a syringe exchange program in New York
City (51). Among 181 people eligible for influenza vaccine,
86 percent accepted and received vaccination. Forty-eight
people reported a chronic medical condition, and 87 percent
of them were vaccinated.
Large-scale regional programs
Fourteen studies have evaluated large-scale regional vac-
cination interventions in different populations using a variety
of approaches alone or in combination. Thirteen focused
on the elderly, and one focused on the elderly and adults
with high-risk conditions. Settings included regional public
health programs (52–54), targeting of Medicare beneficia-
ries in a specific region (46, 55–61), and pharmacy-based
vaccine distribution (62, 63). In terms of approaches, six
studies have used mailings to the target population either
alone (53, 57, 60, 64) or in combination with an educational
insert or brochure (55, 58) or a media campaign (46, 54).
Letters alone increased vaccination coverage 5–33 percent
in those studies that had a comparison group (46, 53, 55, 57–
60); however, mailed reminders were not always effective in
improving coverage (58, 59).
Multicomponent programs were among the most success-
ful at vaccinating high-risk individuals. One study reported
on an effort to expand an existing influenza vaccination
program by adding urban outreach clinics as well as open
clinics at proprietary homes and senior nutrition centers and
by enrolling area nursing homes, local hospitals, local home
health agencies, and primary-care physicians (56). Special
arrangements were made with the local health maintenance
organization and individual practice association to enable
participation. This demonstration project resulted in an
immunization rate of 74.3 percent among 88,881 Medicare
beneficiaries aged 65 years or older.
Two studies examined the effectiveness of pharmacy-based
vaccination programs in the United States. Grabenstein et al.
(63) compared urban chain pharmacies inWashington, where
pharmacists could legally administer influenza vaccines, with
similar pharmacies in Oregon, where pharmacists could
not vaccinate. Although no significant differences were re-
ported, vaccination coverage in Oregon remained stable and
increased by 4.7 percent in Washington between 1997 and
1998. Steyer et al. (62) compared vaccination coverage in
eight states where pharmacists could administer vaccine
with eight states where they could not. Between 1995 and
1999, vaccine coverage increased by 10.7 percent in states
where pharmacists could administer vaccine and 3.5 percent
in states where they could not. The difference between years
was significant, as was the difference between states in 1999.
One study evaluated the impact of home visits to the el-
derly by a public health nurse on vaccination coverage (52).
There were no significant differences in vaccine uptake
among the intervention group versus the control group (56.1
percent vs. 56.6 percent). However, significantly more people
in the intervention group reported talking about immuniza-
tion with the public health nurse (42.2 percent vs. 18.2 percent
of controls).
Immunization distribution programs involving active
community engagement
Program descriptions thus far have been medicine or pub-
lic health directed. Another approach involves community–
academic–local health department partnerships. Partnerships
between researchers and community representatives that
facilitate participation in defining the research problem,
interpreting the data, and applying the findings can help
address trust issues and translation of research into practice
and policy (65). Four studies have used community en-
gagement techniques to implement vaccination programs
(66–69). In their program aimed at increasing influenza
vaccination coverage among indigenous adults in Australia,
Hanna et al. (66) involved key stakeholders in early plan-
ning and promotion and recruited indigenous public health
workers to promote the program and develop materials.
Community-wide programs are less commonly reported.
Weatherill et al. (67) evaluated a large-scale vaccination
‘‘blitz’’ in an inner-city neighborhood of 10 square blocks
with 12,000 injection drug users who lived or spent time
there. The researchers held an informational stakeholder
meeting, which included local agencies, physicians, clinic
representatives, and large businesses, to apprise the com-
munity of the program. Resident volunteers were recruited
for distribution. Distribution sites included single room
occupancy hotels, soup kitchens, food banks, community
agencies, needle exchanges, drop-in centers, pubs, medical
clinics, jails or pretrial centers, parks, streets, and alleys.
Influenza vaccines were distributed to 8,043 people in 1999,
3,718 in 2000, 5,175 in 2001, and 4,131 in 2002. A decrease
in emergency department visits for pneumonia was noted in
2000, although this reduction was confounded by differ-
ences in the timing and magnitude of the 1999 and 2000
influenza epidemics.
Two studies used a more community-directed approach.
Working with faith-based neighborhood health centers,
Zimmerman et al. (69) evaluated interventions aimed at
vaccinating inner-city adults aged 50 years or older. The
researchers offered a selection of intervention components
derived from the US Task Force on Community Preventive
Services (70) to two faith-based centers. Centers chose com-
ponents that best suited their particular circumstances. Both
centers selected examination room posters, free or low-cost
vaccines for indigent adults, staff education, chart remind-
ers, and standing orders. One center (center A) also chose to
use mailings, while the other (center B) chose community
advertisement and off-site vaccination clinics. There were
no significant differences in vaccination rates before and
after the intervention. Vaccination rates were 59 percent for
center A and 49 percent for center B; this difference was
not statistically significant. Adults aged 65 years or older
were significantly more likely to be vaccinated compared
with those aged 50–64 years (65 percent vs. 47 percent). In a
similar study, Zimmerman et al. (68) worked with urban
health centers to target children less than 2 years of age
for the recommended initial two doses of influenza vaccine.
The researchers again asked their community partners to
choose intervention components that best suited their needs.
Postintervention vaccination coverage increased from 6.5
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percent to 38.5 percent for the first dose and from 1.9
percent to 13.2 percent for the second dose compared with
preintervention. Including influenza vaccine did not delay
receipt of other childhood vaccines.
LIMITATIONS OF THE CURRENT LITERATURE
In evaluating interventions to vaccination, several meth-
odological issues, limitations, and gaps should be consid-
ered. Methodologically, we note that enumerating the target
group and collecting data on vaccination rates is challeng-
ing. In epidemiologic studies, clear enumeration of the tar-
get group is necessary for estimating vaccination coverage.
Studies conducted in health-care settings, or with the use of
governmental lists (e.g., Medicare recipients and municipal
records) are able to accurately determine vaccination cover-
age insofar as these lists are complete. However, a number
of important subpopulations may not be reflected in these
enumerations, including the homeless and undocumented
immigrants. Studies that use community settings are often
challenged by the need to precisely enumerate their target
populations.
Another methodological challenge is accurate documen-
tation of vaccination rates. For studies involving medical
claims data, these data may be lagged and physicians may
bill for vaccinations separately, as reported earlier (16).
Other studies have relied on patient or parent self-report.
Zimmerman et al. (71) demonstrated that these methods can
be problematic: sensitivity was 98 percent and specificity
was 38 percent for self-reported influenza vaccination
among elderly outpatients and was 85.7 percent and 66
percent, respectively, among parents of children aged 6–23
months (72).
The current literature is limited with respect to compre-
hensive coverage of high-risk groups and key subpopula-
tions. Of 56 studies examined, 40 (71.4 percent) targeted the
elderly, 14 (25.0 percent) were directed at adults with high-
risk conditions, and five (8.9 percent) targeted children.
More than half of the studies (n = 30) occurred in primary-
care settings, 14 (25.0 percent) were large-scale regional pro-
grams, four (7.1 percent) were in tertiary-care facilities or
hospitals, four (7.1 percent) were targeted to nursing homes
or long-term-care facilities, three (5.4 percent) included
active community engagement, and two (3.6 percent) were
targeted to specific communities. Thus, most studies exam-
ined vaccination within the context of primary-care settings
or large-scale regional programs. An important limitation of
these types of approaches is their inability to reach those
people not engaged in the health-care system. Given the
number of Americans without health insurance, the need for
alternative methods for providing influenza vaccinations is
clear. Beyond lack of health insurance, a variety of other
personal and structural barriers may limit appropriate vac-
cination coverage, including mistrust of modern medicine
or the government, availability, convenience, and concern
about side effects (73–77).
Targeted efforts to deliver influenza vaccine to high-risk
groups have resulted in higher influenza vaccination rates
among persons who are most at risk of influenza compared
with the general population; however, vaccination rates in
these target groups are not optimal. There are substantial
disparities between and within high-risk groups. For ex-
ample, data from the 1999 National Health Interview Survey
reveal that Black adults with high-risk conditions such as
diabetes, chronic heart disease, and cancer, compared with
White adults with the same conditions, had a significantly
lower prevalence of influenza vaccination (78). Although
increasing attention has been given to racial/ethnic and
socioeconomic status disparities in health and health-care
access, only seven of 54 studies reviewed considered race/
ethnicity or socioeconomic status characteristics with re-
spect to vaccination uptake. One study presented influenza
immunization data for the United States and for Louisiana
by race but did not examine it as a correlate of vaccine up-
take in their intervention (57). Three studies reported no dif-
ference in vaccination status by race (62, 69, 79), and one
study showed a decreased likelihood for vaccination among
Blacks (62). Weaver et al. (42) found that vaccine recipients
were significantly more likely to be White, but possible ex-
planations for the differences were not reported. Zimmerman
et al. (68) reported differences in vaccine uptake by race/
ethnicity in their study of inner-city children, but they were
cautious in drawing conclusions because race/ethnicity was
not available for a substantial number of study participants.
Only one study examined socioeconomic status in terms
of vaccination uptake. Spaulding and Kugler (18) found that
enlisted military beneficiaries were less likely than officers
to be vaccinated. Our review of the literature suggests
that there is a substantial gap in the literature with respect
to reporting vaccination rates for interventions by race/
ethnicity and/or socioeconomic status. Given that disparities
in vaccination continue to be documented, understanding
how programs address, or do not address, the needs of these
groups is essential.
Low vaccination coverage among minorities and persons
living in and near poverty is a persistent problem. Although
there is a paucity of empiric evidence in this regard, pre-
vious infectious disease epidemics have been accompanied
by concerns about the possible spread of disease through
populations with relatively low vaccination rates. In the last
smallpox epidemic in the United States (1901–1903 in
Boston, Massachusetts), there were 1,596 recorded cases of
smallpox (with a case fatality rate of 17 percent). A con-
certed effort by public health officials to forcibly vaccinate
all homeless persons in Boston, while controversial, pre-
ceded resolution of the smallpox epidemic at the time (80).
Vaccination rates for most vaccine-preventable diseases
are particularly low among marginalized, difficult-to-reach
(or ‘‘hidden’’) populations (e.g., injection drug users, el-
derly shut-ins) within disadvantaged urban communities
(81–83). Few studies have made concerted attempts to vac-
cinate difficult-to-reach populations for influenza, such as
the homeless, substance users, elderly shut-ins, and un-
documented immigrants. With few notable exceptions, the
interventions we reviewed engaged people already formerly
connected to health-care or social services. Two studies
stand out: Stancliff et al. (51) offered vaccine at a syringe
exchange program, andWeatherill et al. (67) offered vaccine
in a variety of nontraditional settings.
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Most interventions that we reviewed were not community
based but relied on programs that were professionally di-
rected and administered. However, community-based par-
ticipatory research is emerging as one of the more effective
methods for addressing health disparities (84). Recent
reviews of intervention studies have overwhelmingly con-
cluded that population-level intervention research should
include an expanded appreciation of social, environmental,
and health policy components of health promotion (85, 86).
New directions that have been suggested for community
intervention studies consist of involving a diverse team in-
cluding community members in program planning and im-
plementation (87). We reviewed five studies that involved
the community, all of which occurred after 2000. Moving
forward, we anticipate that more programs will begin to use
community-based participatory research as a powerful tool
to improve health.
SUMMARY AND FUTURE RESEARCH
Between 1990 and 2006, a number of studies examined
interventions to increase influenza vaccination among high-
risk populations. In the United States, a goal has been set
to ensure 90 percent vaccination coverage for adults aged
65 years or older and 60 percent for high-risk adults aged
18–64 years (6). Only a handful of the studies we reviewed
managed to meet that goal for their target populations.
Interventions that increased vaccination rates to the goals
outlined by Healthy People 2010 included advertising (42,
48), provider (42) and patient (14, 42) mailings, registry-
based telephone calls (35), patient and staff education (48),
standing orders coupled with standardized forms (14),
targeting of syringe exchange customers (51), and visiting
nurses (41).
During the 2004–2005 influenza season, coverage was
estimated at 62.7 percent for people aged 65 years or older
and 25.5 percent for people aged 18–64 years with a high-
risk condition (8), which was lower than for the 2003 influ-
enza season, where coverage was 69.9 percent among adults
aged 65 years or older and, among adults aged 18–64 years,
34.0 percent for those with asthma and 49.0 percent for
those with diabetes (7). Although there was a substantial in-
fluenza vaccine shortage in 2004–2005, those coverage rates
highlight the effort still needed to meet national goals.
This review has focused on those at high risk of com-
plications from influenza; however, those at high risk of
transmitting influenza are also an important target group for
vaccination programs. For example, epidemiologic models
(88) and several Japanese studies have suggested that vac-
cinating schoolchildren for influenza can reduce morbidity
and mortality among adults (89, 90). The Advisory Com-
mittee on Immunization Practices does not currently recom-
mend influenza vaccination for healthy schoolchildren (5).
There are two primary areas in which future research can
make a valuable contribution. First, there is a paucity of
research that evaluates the impact of vaccination programs
by race/ethnicity and socioeconomic status. Given the grow-
ing disparities in health and health-care access among
racial/ethnic minorities and individuals with low socioeco-
nomic status attainment, understanding the way in which
interventions can remedy these differences is crucial. Sec-
ond, few studies have targeted individuals outside of the
health-care and social services sectors. To reach those who
do not have health insurance and are not connected to social
services, interventions that move away from these settings
are needed.
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